Clinical trial Recruiting at 1 site Interventional Ages 14 and up Women only

Digital support to improve adherence to multiple micronutrient supplements during pregnancy

Official title: A Randomized Controlled Trial in Lombok: Assessing Factors Influencing Acceptance and Adherence to Multiple Micronutrient Supplementation (MMS) Using Digital Tools

Run by Summit Institute for Development, Indonesia · NCT07555093 · Data updated 2026-11-12

This trial tests whether a digital health program helps pregnant women take MMS more consistently, and whether packaging or adding calcium makes a difference.

Quick facts

Study typeInterventional
Ages14 Years and up
SexWomen only
Enrollment10012 (estimated)
SponsorSummit Institute for Development, Indonesia
Academic / other
Locations1 site (Mataram, West Nusa Tenggara)
StatusRecruiting
StartedJune 13, 2026
Main results expectedMay 2027
Study endsJune 2027
Registry record updatedJuly 1, 2026
Trial IDNCT07555093 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant women up to 32 weeks gestation who remain in the study site for the duration of the trial.

Probably not a fit

Women who move away, are lost to follow-up, or experience adverse events that lead to withdrawal may not receive the intended benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a two-stage, cluster-randomized trial conducted in Lombok Island to see if a digital health approach can improve adherence to multiple micronutrient supplementation among pregnant women. The first stage compares standard care to digital-supported delivery in four arms that vary by MMS packaging (bottle vs blister) and delivery method. The second stage adds a calcium supplementation arm at the community-health-post level to assess incremental adherence. Approximately 10,012 pregnant women are enrolled across clusters, with data collected on adherence, feasibility, and integration into routine antenatal care.

Why it matters

Potential benefit: If successful, digital tools could significantly improve MMS adherence and potentially maternal and newborn health outcomes in similar settings.

How similar studies have gone: Prior studies in digital health and adherence strategies have shown promise for improving supplement adherence in various populations, though this exact MMS and packaging/delivery combination is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant women up to 32 weeks
* Pregnant women stay in the site at least during the study period

Exclusion Criteria:

* Lost to follow up
* Moving to another area
* Death
* Abortus
* Stillbirth

Where it's running

  • Summit Institute for Development
    Mataram, West Nusa Tenggara, Indonesia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.